Madden Securities’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-482
Closed -$279K 123
2025
Q4
$279K Hold
482
0.09% 104
2025
Q3
$234K Buy
+482
New +$224K 0.07% 105
2025
Q2
Sell
-612
Closed -$305K 122
2025
Q1
$305K Hold
612
0.12% 95
2024
Q4
$318K Hold
612
0.13% 96
2024
Q3
$379K Hold
612
0.16% 83
2024
Q2
$338K Sell
612
-17
-3% -$9.74K 0.15% 89
2024
Q1
$366K Sell
629
-158
-20% -$88.7K 0.17% 77
2023
Q4
$418K Hold
787
0.22% 69
2023
Q3
$398K Hold
787
0.23% 66
2023
Q2
$411K Sell
787
-67
-8% -$36.2K 0.21% 66
2023
Q1
$492K Hold
854
0.26% 64
2022
Q4
$470K Sell
854
-25
-3% -$13.2K 0.25% 67
2022
Q3
$446K Hold
879
0.27% 69
2022
Q2
$478K Sell
879
-200
-19% -$110K 0.26% 70
2022
Q1
$637K Buy
1,079
+425
+65% +$244K 0.29% 61
2021
Q4
$436K Sell
654
-10
-2% -$6.24K 0.2% 76
2021
Q3
$379K Sell
664
-1,500
-69% -$823K 0.21% 82
2021
Q2
$1.09M Hold
2,164
0.57% 49
2021
Q1
$988K Sell
2,164
-75
-3% -$35.8K 0.58% 49
2020
Q4
$1.04M Hold
2,239
0.67% 45
2020
Q3
$989K Buy
2,239
+1,510
+207% +$624K 0.74% 37
2020
Q2
$264K Buy
+729
New +$244K 0.24% 86

Other funds holding TMO

Madden Securities's TMO Position: Q1 2026 in Review

Madden Securities sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 482 shares — an estimated $279K sold.

Madden Securities first reported a position in TMO in Q2 2020 and held it in 22 quarters. The position peaked at $1.09M in Q2 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Madden Securities reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Madden Securities sold 482 Thermo Fisher Scientific shares in Q1 2026, an estimated $279K.
  • Madden Securities first reported a position in Thermo Fisher Scientific in Q2 2020 and held it in 22 quarters.
  • Madden Securities's Thermo Fisher Scientific position peaked at $1.09M in Q2 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Madden Securities's 13F filing for Q1 2026, filed 5 May 2026.